ITMI912212A1 - Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica - Google Patents
Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastricaInfo
- Publication number
- ITMI912212A1 ITMI912212A1 IT002212A ITMI912212A ITMI912212A1 IT MI912212 A1 ITMI912212 A1 IT MI912212A1 IT 002212 A IT002212 A IT 002212A IT MI912212 A ITMI912212 A IT MI912212A IT MI912212 A1 ITMI912212 A1 IT MI912212A1
- Authority
- IT
- Italy
- Prior art keywords
- oral administration
- pharmaceutical compositions
- solid pharmaceutical
- prohibited
- gastric residence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI912212A IT1251153B (it) | 1991-08-06 | 1991-08-06 | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica |
DE69208299T DE69208299T2 (de) | 1991-08-06 | 1992-08-03 | Feste Arzneizubereitungen zur oralen Verabreichung mit verlängerter Magenverweilzeit |
AT92113187T ATE134134T1 (de) | 1991-08-06 | 1992-08-03 | Feste arzneizubereitungen zur oralen verabreichung mit verlängerter magenverweilzeit |
ES92113187T ES2086029T3 (es) | 1991-08-06 | 1992-08-03 | Composiciones farmaceuticas solidas para la administracion oral con permanencia gastrica prolongada. |
EP92113187A EP0526862B1 (en) | 1991-08-06 | 1992-08-03 | Solid pharmaceutical compositions for oral administration with prolonged gastric residence |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI912212A IT1251153B (it) | 1991-08-06 | 1991-08-06 | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI912212A0 ITMI912212A0 (it) | 1991-08-06 |
ITMI912212A1 true ITMI912212A1 (it) | 1993-02-07 |
IT1251153B IT1251153B (it) | 1995-05-04 |
Family
ID=11360543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI912212A IT1251153B (it) | 1991-08-06 | 1991-08-06 | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0526862B1 (it) |
AT (1) | ATE134134T1 (it) |
DE (1) | DE69208299T2 (it) |
ES (1) | ES2086029T3 (it) |
IT (1) | IT1251153B (it) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3332426B2 (ja) * | 1992-10-02 | 2002-10-07 | 太田製薬株式会社 | 大腸および小腸の検査用x線造影剤 |
WO1994020074A1 (en) * | 1993-03-12 | 1994-09-15 | The Procter & Gamble Company | Adsorbate compositions |
FR2703250A1 (fr) * | 1993-03-30 | 1994-10-07 | Chicouri Marcel | Nouvelles compositions pharmaceutiques à base de bismuth et leur procédé de préparation. |
US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
NZ260408A (en) | 1993-05-10 | 1996-05-28 | Euro Celtique Sa | Controlled release preparation comprising tramadol |
IT1265074B1 (it) * | 1993-05-18 | 1996-10-30 | Istituto Biochimico Italiano | Composizione farmaceutica a lento rilascio contenente come sostanza attiva un acido biliare |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5891471A (en) | 1993-11-23 | 1999-04-06 | Euro-Celtique, S.A. | Pharmaceutical multiparticulates |
KR100354702B1 (ko) | 1993-11-23 | 2002-12-28 | 유로-셀티크 소시에떼 아노뉨 | 약학조성물의제조방법및서방형조성물 |
DE4404011A1 (de) * | 1994-02-09 | 1995-08-10 | Jenapharm Gmbh | Neue, adhäsiv wirkende Zubereitungen für mit Flüssigkeit benetzte Oberflächen, Verfahren und Vorrichtung zur Erfassung der Adhäsionszeit diesbezüglicher Zubereitungen |
US5843480A (en) | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
CH687810A5 (de) * | 1995-05-24 | 1997-02-28 | Mepha Ag | Pelletformulierung mit Omeprazol. |
WO1996039126A2 (en) * | 1995-06-06 | 1996-12-12 | Warner-Lambert Company | Ranitidine salts on magnesium trisilicate as an adsorbate |
ES2112765B1 (es) * | 1995-08-02 | 1999-03-01 | Cantabria Ind Farmaceutica Sa | Procedimiento para la obtencion de formulaciones de constraste radiologico, para exploraciones gastrointestinales de uso extemporaneo y directo. |
DE19533162A1 (de) * | 1995-09-08 | 1997-03-13 | Bayer Ag | Pharmazeutisches Kombinationspräparat mit Ketoprofen |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
US5985312A (en) * | 1996-01-26 | 1999-11-16 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers |
US6368586B1 (en) | 1996-01-26 | 2002-04-09 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers |
GB9607955D0 (en) * | 1996-04-17 | 1996-06-19 | Tillotts Pharma Ag | Hydrophobic carbomer salt compositions |
JPH10513202A (ja) * | 1996-06-11 | 1998-12-15 | ゾナジェン,インコーポレイテッド | キトサン薬物送達システム |
AU5446798A (en) * | 1996-11-27 | 1998-06-22 | Procter & Gamble Company, The | Compositions and methods for the treatment of gastrointestinal disorders |
GB2329334A (en) * | 1997-09-18 | 1999-03-24 | Reckitt & Colmann Prod Ltd | Cholesterol-lowering agents |
SE9704869D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
ID27398A (id) * | 1998-06-05 | 2001-04-05 | Warner Lambert Co | Stabilisasi komposisi yang mengandung inhibitor ace dengan menggunakan magnesium oksida |
CA2507743C (en) | 1998-08-12 | 2008-03-18 | Altana Pharma Ag | Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
US6319513B1 (en) | 1998-08-24 | 2001-11-20 | The Procter & Gamble Company | Oral liquid mucoadhesive compounds |
ATE424810T1 (de) * | 1998-12-11 | 2009-03-15 | Nostrum Pharmaceuticals Inc | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung |
DE19918325A1 (de) | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
AU1169601A (en) * | 1999-11-16 | 2001-05-30 | Ranbaxy Laboratories Limited | Taste masked oral compositions |
DE60123384T2 (de) * | 2000-02-04 | 2007-08-02 | DepoMed, Inc., Menlo Park | Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert |
US6248360B1 (en) | 2000-06-21 | 2001-06-19 | International Health Management Associates, Inc. | Complexes to improve oral absorption of poorly absorbable antibiotics |
AU6701101A (en) * | 2000-06-21 | 2002-01-02 | Cubist Pharm Inc | Compositions and methods to improve the oral absorption of antimicrobial agents |
US7527807B2 (en) | 2000-06-21 | 2009-05-05 | Cubist Pharmaceuticals, Inc. | Compositions and methods for increasing the oral absorption of antimicrobials |
GB2373438A (en) * | 2001-02-10 | 2002-09-25 | Reckitt & Colmann Prod Ltd | Cholesterol lowering compositions |
HUP0501071A3 (en) * | 2001-03-13 | 2007-06-28 | Penwest Pharmaceutical Co | Chronotherapeutic dosage forms |
US20030158254A1 (en) * | 2002-01-24 | 2003-08-21 | Xenoport, Inc. | Engineering absorption of therapeutic compounds via colonic transporters |
EP1663156A2 (en) | 2003-09-19 | 2006-06-07 | Penwest Pharmaceuticals Company | Chronotherapeutic dosage forms |
CA2539051C (en) | 2003-09-19 | 2014-08-12 | Penwest Pharmaceuticals Co. | Delayed release dosage forms |
TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
DE102004023069A1 (de) | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
US8968781B2 (en) | 2005-04-29 | 2015-03-03 | Cubist Pharmaceuticals, Inc. | Therapeutic compositions |
AU2007291509B2 (en) | 2006-08-30 | 2013-05-02 | Jagotec Ag | Controlled release oral dosage formulations comprising a core and one or more barrier layers |
AU2013202344B2 (en) * | 2006-08-30 | 2014-07-17 | Jagotec Ag | Controlled release oral dosage formulations comprising a core and one or more barrier layers |
CN101516352A (zh) * | 2006-08-30 | 2009-08-26 | 雅戈泰克股份公司 | 包含尼索地平的控释固体口服制剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3431861A1 (de) * | 1984-08-30 | 1986-03-13 | Troponwerke GmbH & Co KG, 5000 Köln | Pellet-zubereitung |
GB2196252B (en) * | 1986-09-18 | 1990-10-17 | London Pharmacy Innovation | Gastric controlled-release dosage forms |
-
1991
- 1991-08-06 IT ITMI912212A patent/IT1251153B/it active IP Right Grant
-
1992
- 1992-08-03 ES ES92113187T patent/ES2086029T3/es not_active Expired - Lifetime
- 1992-08-03 EP EP92113187A patent/EP0526862B1/en not_active Expired - Lifetime
- 1992-08-03 AT AT92113187T patent/ATE134134T1/de not_active IP Right Cessation
- 1992-08-03 DE DE69208299T patent/DE69208299T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0526862B1 (en) | 1996-02-14 |
ES2086029T3 (es) | 1996-06-16 |
IT1251153B (it) | 1995-05-04 |
ITMI912212A0 (it) | 1991-08-06 |
EP0526862A1 (en) | 1993-02-10 |
DE69208299T2 (de) | 1996-07-18 |
ATE134134T1 (de) | 1996-02-15 |
DE69208299D1 (de) | 1996-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI912212A1 (it) | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica | |
NZ244021A (en) | Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof | |
IE862554L (en) | Pharmaceutical compositions | |
ATE310519T1 (de) | Arzneizusammensetzungen enthaltend ascomyzinderivate | |
ES2152966T3 (es) | Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion. | |
AU640137B2 (en) | Novel arylpyridazines, their manufacture, use and medicaments containing them | |
UA32525C2 (uk) | Стійка до шлункового соку форма лікарського засобу на основі пантопразолу для орального введення | |
NO900356L (no) | Blandinger med forsinket frigjoering. | |
IT1211484B (it) | Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo | |
AU6542986A (en) | Pyridyl-methylthio substituted benzimidazoles | |
SE8300736D0 (sv) | Novel pharmacologically active compounds | |
CA2108455A1 (en) | Pharmaceutical compositions against gastric disorders | |
IL101883A0 (en) | Antiviral combinations and pharmaceutical compositions containing them | |
EP0781561A4 (en) | NEW MEDICAL USE OF A 5HT 3 ANTAGONIST? | |
GB2259647B (en) | Medicaments for treating gastrointestinal disorders | |
IT1275816B1 (it) | Composizioni farmaceutiche solide per uso vaginale | |
NZ240575A (en) | N-benzoylproline derivatives and pharmaceutical compositions | |
DK0505180T3 (da) | Farmaceutisk præparat med højt indhold af ibuprofenlysinat | |
ES2091570T3 (es) | Nuevos derivados peptidicos antagonistas de la bradiquidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ATE85218T1 (de) | Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid. | |
IT1204778B (it) | Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale | |
IL93721A0 (en) | Mixed micelles compositions and their use as carriers for the parenteral application of the drugs | |
EP0481288A3 (en) | N-phenyl-piperidyl-4-amines and drugs containing them | |
IL85508A (en) | 2-substituted-4-(2-benzyl-aminophenyl)-1,4,5,7-tetra-hydro-5-oxofuro(3,4,-b)-pyridine-3-carboxylic acid derivatives and pharmaceutical compositions containing them | |
IT8719967A0 (it) | Procedimento per l'estrazione e la purificazione dalla propoli di una miscela di principi attivi dotatadi notevoli proprieta'antiossidanti. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19960830 |